03:55 PM EDT, 07/23/2024 (MT Newswires) -- Health care stocks advanced late Tuesday afternoon, with the NYSE Health Care Index adding 0.2% and the Health Care Select Sector SPDR Fund (XLV) up 0.1%.

The iShares Biotechnology ETF (IBB) decreased 0.3%.

In corporate news, Adial Pharmaceuticals ( ADIL ) shares surged nearly 35% after the company reported the progression to the second group in a trial of AD04 to treat alcohol use disorder in heavy drinking patients, following the completion of the first group.

Azitra ( AZTR ) skyrocketed 209% after it said Tuesday that the US Patent and Trademark Office granted it a patent that covers future potential pipeline candidates for indications including atopic dermatitis.

Medpace ( MEDP ) shares tumbled 18%, a day after the company cut its 2024 revenue outlook.

SeaStar Medical ( ICU ) shares gained 9.3% after the company treated the first person in a commercial setting with Quelimmune, a therapy for acute kidney injury in pediatric patients.